These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10976529)

  • 21. Efficient synthesis of 2-modified 1alpha,25-dihydroxy-19-norvitamin D3 with Julia olefination: high potency in induction of differentiation on HL-60 cells.
    Ono K; Yoshida A; Saito N; Fujishima T; Honzawa S; Suhara Y; Kishimoto S; Sugiura T; Waku K; Takayama H; Kittaka A
    J Org Chem; 2003 Sep; 68(19):7407-15. PubMed ID: 12968893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological characterization of 1alpha,24,25-trihydroxy-2beta-(3-hydroxypropoxy)vitamin D(3) (24-hydroxylated ED-71).
    Hatakeyama S; Kawase A; Uchiyama Y; Maeyama J; Iwabuchi Y; Kubodera N
    Steroids; 2001; 66(3-5):267-76. PubMed ID: 11179734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of substituting fluorine for hydrogen at C-26 and C-27 on the side chain of 1,25-dihydroxyvitamin D3.
    Inaba M; Okuno S; Nishizawa Y; Imanishi Y; Katsumata T; Sugata I; Morii H
    Biochem Pharmacol; 1993 Jun; 45(11):2331-6. PubMed ID: 8517874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y; Pike JW; Koeffler HP
    Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological activities of 2alpha-substituted analogues of 1alpha,25-dihydroxyvitamin D3 in transcriptional regulation and human promyelocytic leukemia (HL-60) cell proliferation and differentiation.
    Takahashi E; Nakagawa K; Suhara Y; Kittaka A; Nihei K; Konno K; Takayama H; Ozono K; Okano T
    Biol Pharm Bull; 2006 Nov; 29(11):2246-50. PubMed ID: 17077522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 14-epi-2α-hydroxypropoxy-1α,25-dihydroxy-19-nortachysterol and its hVDR binding.
    Sawada D; Tsukuda Y; Saito H; Takagi K; Kakuda S; Takimoto-Kamimura M; Ochiai E; Takenouchi K; Kittaka A
    J Steroid Biochem Mol Biol; 2013 Jul; 136():27-9. PubMed ID: 23246987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent developments for introducing a hexafluoroisopropanol unit into the Vitamin D side chain.
    Kawagoe F; Sugiyama T; Uesugi M; Kittaka A
    J Steroid Biochem Mol Biol; 2018 Mar; 177():250-254. PubMed ID: 28716761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of all A-ring stereoisomers of 5,6-trans-2-methyl-1,25-dihydroxyvitamin D(3) and their 20-epimers: possible binding modes of potent A-ring analogues to vitamin D receptor.
    Fujishima T; Konno K; Nakagawa K; Tanaka M; Okano T; Kurihara M; Miyata N; Takayama H
    Chem Biol; 2001 Nov; 8(11):1011-24. PubMed ID: 11731293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D
    Szybinski M; Sektas K; Sicinski RR; Plum LA; Frelek J; DeLuca HF
    J Steroid Biochem Mol Biol; 2017 Jul; 171():144-154. PubMed ID: 28285018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
    Sicinski RR; Prahl JM; Smith CM; DeLuca HF
    J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological activity of vitamin D3 analogues.
    Ikekawa N
    J Steroid Biochem; 1983 Jul; 19(1C):907-11. PubMed ID: 6310260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of a 3-position diastereomer of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71).
    Hatakeyama S; Nagashima S; Imai N; Takahashi K; Ishihara J; Sugita A; Nihei T; Saito H; Takahashi F; Kubodera N
    Bioorg Med Chem; 2006 Dec; 14(23):8050-6. PubMed ID: 16908172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methyl-introduced A-ring analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological evaluation.
    Fujishima T; Tsutsumi R; Negishi Y; Fujii S; Takayama H; Kittaka A; Kurihara M
    Anticancer Res; 2006; 26(4A):2633-6. PubMed ID: 16886673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological activity of 2-methyl-20-epi analogues of 1 alpha,25-dihydroxyvitamin D3.
    Fujishima T; Liu Z; Miura D; Chokki M; Ishizuka S; Konno K; Takayama H
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2145-8. PubMed ID: 9873502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic studies of vitamin D analogues. XVII. Synthesis and differentiation-inducing activity of 1 alpha,24-dihydroxy-22-oxavitamin D3 analogues and their 20(R)-epimers.
    Kubodera N; Watanabe H; Miyamoto K; Matsumoto M; Matsuoka S; Kawanishi T
    Chem Pharm Bull (Tokyo); 1993 Sep; 41(9):1659-63. PubMed ID: 8221979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activity of 1 alpha,23,25,26-tetrahydroxyvitamin D3.
    Ishizuka S; Reichel H; Norman AW
    Arch Biochem Biophys; 1987 Apr; 254(1):188-95. PubMed ID: 3034157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and properties of 14-epi-1α,25-dihydroxy-19-nortachysterol and its 2-substituted derivatives.
    Sawada D; Kittaka A
    Curr Top Med Chem; 2014; 14(21):2454-9. PubMed ID: 25486940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1alpha,25-dihydroxyvitamin D(3) receptor?
    Mohr SC; Swamy N; Xu W; Ray R
    Steroids; 2001; 66(3-5):189-201. PubMed ID: 11179726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syntheses and differentiating action of vitamin D endoperoxides. Singlet oxygen adducts of vitamin D derivatives in human myeloid leukemia cells (HL-60).
    Yamada S; Yamamoto K; Naito H; Suzuki T; Ohmori M; Takayama H; Shiina Y; Miyaura C; Tanaka H; Abe E
    J Med Chem; 1985 Sep; 28(9):1148-53. PubMed ID: 2993611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
    Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
    Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.